Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
BTG
MedTech
Boston Scientific’s radioactive implant extends cancer survival
A new study showed Boston Scientific's radioactive glass microsphere can safely shrink inoperable liver tumors and help patients live longer.
Conor Hale
Mar 29, 2021 11:58am
Boston Scientific sells off BTG's antidote business for $800M
Dec 1, 2020 11:01am
Though sales are up, Boston Scientific's net Q1 profit shrinks
Apr 29, 2020 11:05am
FTC requests info from Boston Scientific, BTG before $4.2B deal
Feb 15, 2019 10:20am
Boston Scientific makes $4.2B offer to buy out BTG
Nov 20, 2018 11:11am
Carrick bags ex-Onyx cancer drug, plans pivotal trials
Oct 11, 2018 8:38am
